EMN Form 4: Director Damon Audia purchases 1,465 shares

Rhea-AI Filing Summary

Damon J. Audia, a director of Eastman Chemical Company (EMN), purchased 1,465 shares of common stock on 08/27/2025 at a price of $68.585 per share. After the transaction he beneficially owned 1,597 shares. The Form 4 was signed under power of attorney by Mark D. Austin on 08/28/2025. The filing reports a direct acquisition by a director and does not disclose derivative transactions.

Positive

• Director purchase disclosed: Damon J. Audia acquired 1,465 shares, which can be interpreted as a personal investment signal by management.

Negative

• None.

Insights

Financial Analyst

TL;DR: A company director made a modest direct purchase of 1,465 shares, increasing his stake to 1,597 shares.

The transaction is a straightforward open-market purchase reported on Form 4: 1,465 shares acquired at $68.585 each on 08/27/2025. For a company of Eastman's scale this is small and unlikely to change valuation or governance dynamics. It may be interpreted as a modest signal of confidence by the director but lacks materiality given the absolute share count and value.

Corporate Governance Expert

TL;DR: Insider purchase by a director is a routine disclosure and raises no governance concerns.

The filing shows a direct purchase by Director Damon J. Audia and proper reporting via Form 4, signed by an authorized attorney-in-fact. There are no amendments, derivative holdings, or indications of coordinated filings. From a governance perspective this is compliant and routine; the size of the purchase does not suggest a change in control or significant alignment shift.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Audia Damon J

(Last) (First) (Middle)

200 SOUTH WILCOX DR

(Street)

KINGSPORT TN 37660

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/27/2025		P		1,465	A	$68.585	1,597	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Mark D. Austin, by Power of Attorney for Damon J. Audia	08/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Damon J. Audia report on the Form 4 for EMN?

The Form 4 reports a direct acquisition of 1,465 shares of Eastman Chemical (EMN) common stock on 08/27/2025 at $68.585 per share, resulting in 1,597 shares beneficially owned.

Was the Form 4 for EMN signed and when?

The Form 4 was signed under power of attorney by Mark D. Austin on 08/28/2025.

Does the filing show any derivative transactions for EMN?

No. Table II for derivative securities contains no entries; the filing discloses only a non-derivative common stock purchase.

Is the filing an individual or joint filing for EMN?

The filing is by one reporting person (individual filing) as indicated on the Form 4.

What is the reporting person’s relationship to Eastman Chemical (EMN)?

Damon J. Audia is reported as a Director of Eastman Chemical Company on the Form 4.